Clinical usefulness of serum HER2 in gastric cancer (Serum Her2/neu elevation in gastric cancer; A Multicenter trial in Hokkaido)
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000009773
- Lead Sponsor
- First Department of Internal Medicine, Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1)Other malignancies within the last 2 years, except for carcinoma in situ or basal cell carcinoma. 2)Patients who are considered to be ineligible by referring physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between tissue HER2 status and serum HER2 level
- Secondary Outcome Measures
Name Time Method The role of human matrix metalloprotease (MMP) and the ADAM family of zinc-dependent metalloproteases for the ectodomain shedding of HER2 ECD in gastric cancer Association between genetic biomarkers and HER2 status in gastric cancer.